[1] HUANG S, LIU L, TANG X, et al. Research progress on the role of hormones in ischemic stroke. Front Immunol. 2022;13:1062977.
[2] 乔玥,李传辉,赵文博.急性缺血性脑卒中的再灌注治疗的现状与未来[J].首都医科大学学报,2025,46(1):68-70.
[3] RUST R, NIH LR, LIBERALE L, et al. Brain repair mechanisms after cell therapy for stroke. Brain. 2024;147(10):3286-3305.
[4] EJMA M, MADETKO N, BRZECKA A, et al. The Role of Stem Cells in the Therapy of Stroke.Curr Neuropharmacol. 2022;20(3):630-647.
[5] CHUNG JW, CHANG WH, BANG OY, et al. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021;96(7):e1012-e1023.
[6] LAI S, GUO Z. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option. Stem Cell Res Ther. 2024;15(1):312.
[7] TIAN H, TIAN F, MA D, et al. Priming and Combined Strategies for the Application of Mesenchymal Stem Cells in Ischemic Stroke: A Promising Approach. Mol Neurobiol. 2024;61(9):7127-7150.
[8] 张君,姜夕锋,张帆,等.间充质干细胞治疗缺血性脑卒中的临床前研究进展[J].中国医药生物技术,2024,19(6):526-532.
[9] KIM HY, KIM TJ, KANG L, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke. Biomaterials. 2020;243:119942.
[10] XU K, ZHAO X, HE Y, et al. Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models. Front Pharmacol. 2024;15:1481617.
[11] DE PALMA ST, HERMANS EC, SHAMORKINA TM, et al. Hypoxic Preconditioning Enhances the Potential of Mesenchymal Stem Cells to Treat Neonatal Hypoxic-Ischemic Brain Injury. Stroke. 2025. doi: 10.1161/STROKEAHA.124.048964.
[12] KANG H, HUANG Y, PENG H, et al. Mesenchymal Stem Cell-Loaded Hydrogel Improves Surgical Treatment for Chronic Cerebral Ischemia. Transl Stroke Res. 2025;16(3):896-913.
[13] SALEH RO, MAJEED AA, MARGIANA R, et al. Therapeutic gene delivery by mesenchymal stem cell for brain ischemia damage: Focus on molecular mechanisms in ischemic stroke. Cell Biochem Funct. 2024;42(2):e3957.
[14] DENG M, HOU Y, LIU J, et al. Mesenchymal stem cell-derived exosomes overexpressing SRC-3 protect mice from cerebral ischemia by inhibiting ferroptosis. Brain Res Bull. 2024;211:110948.
[15] KURODA Y, KITADA M, WAKAO S, et al. Unique multipotent cells in adult human mesenchymal cell populattons. Proc Natl Acad Sci U S A. 2010; 107(19):8639-8643.
[16] ALANAZI RF, ALHWITY BS, ALMAHLAWI RM, et al. Multilineage Differentiating Stress Enduring (Muse) Cells: A New Era of Stem Cell-Based Therapy. Cells. 2023;12(13):1676.
[17] OSSANNA R, VERONESE S, QUINTERO SIERRA LA, et al. Multilineage-Differentiating Stress-Enduring Cells (Muse Cells): An Easily Accessible, Pluripotent Stem Cell Niche with Unique and Powerful Properties for Multiple Regenerative Medicine Applications. Biomedicines. 2023; 11(6):1587.
[18] GUO Y, XUE Y, WANG P, et al. Muse cell spheroids have therapeutic effect on corneal scarring wound in mice and tree shrews. Sci Transl Med. 2020; 12(562):eaaw1120.
[19] YAMADA Y, MINATOGUCHI S, KANAMORI H, et al. Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells. J Cardiol. 2022;80(1):80-87.
[20] KOYAMA J, YAMASHITA S, KATO Y, et al. Intravenously engrafted human multilineage -differentiating stress-enduring (Muse) cells rescue erectile function after rat cavernous nerve injury. BJU Int. 2024;133(3):332-340.
[21] 张坤,李芳,延冰,等.应激耐受多系分化细胞的研究进展[J].新医学, 2018,49(5):301-304.
[22] 张坤,李芳,肖东杰,等.人脐带与人脂肪间充质干细胞中应激耐受多系分化细胞的分离鉴定及分化能力的比较[J].中国组织工程研究, 2022,26(24):3802-3807.
[23] LI Y, TAN L, YANG C, et al. Distinctions between the Koizumi and Zea Longa methods for middle cerebral artery occlusion (MCAO) model: a systematic review and meta-analysis of rodent data. Sci Rep. 2023; 13(1):10247.
[24] MAO R, ZONG N, HU Y, et al. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022;38(10):1229-1247.
[25] TUO QZ, ZHANG ST, LEI P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42(1):259-305.
[26] HE X, WU M, CHEN L, et al. APMCG-1 attenuates ischemic stroke injury by reducing oxidative stress and apoptosis and promoting angiogenesis via activating PI3K/AKT pathway. Biomed Pharmacother. 2024;180:117506.
[27] QI L, WANG C, DENG L, et al. Low-intensity focused ultrasound stimulation promotes stroke recovery via astrocytic HMGB1 and CAMK2N1 in mice. Stroke Vasc Neurol. 2024;9(5):505-518.
[28] ZHANG Y, DONG N, HONG H, et al. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke. Int J Mol Sci. 2022;23(5):2550.
[29] MOÑIVAS GALLEGO E, ZURITA CASTILLO M. Mesenchymal stem cell therapy in ischemic stroke trials. A systematic review. Regen Ther. 2024;27:301-306.
[30] YANG YK, OGANDO CR, WANG SEE C, et al. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res Ther. 2018;9(1):131.
[31] ZHANG L, ZHUO Y, YU H. Spatio-temporal metabolokinetics and therapeutic effect of CD106(+) mesenchymal stem/stromal cells upon mice with acute lung injury. Cell Biol Int. 2023;47(4):720-730.
[32] ANDREWS PW, GOKHALE PJ. A short history of pluripotent stem cells markers. Stem Cell Reports. 2024;19(1):1-10.
[33] QUE H, MAI E, HU Y, et al. Multilineage-differentiating stress-enduring cells: a powerful tool for tissue damage repair. Front Cell Dev Biol. 2024; 12:1380785.
[34] ABE T, ABURAKAWA D, NIIZUMA K, et al. Intravenously Transplanted Human Multilineage-Differentiating Stress-Enduring Cells Afford Brain Repair in a Mouse Lacunar Stroke Model. Stroke. 2020;51(2):601-611.
[35] SUZUKI T, SATO Y, KUSHIDA Y, et al. Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy. J Cereb Blood Flow Metab. 2021;41(7): 1707-1720.
[36] UCHIDA H, NIIZUMA K, KUSHIDA Y, et al. Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model. Stroke. 2017; 48(2):428-435.
[37] YAMAUCHI T, KURODA Y, MORITA T, et al. Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One. 2015;10(3):e0116009.
[38] LI H, WEI J, LIU X, et al. Muse cells: ushering in a new era of stem cell-based therapy for stroke. Stem Cell Res Ther. 2022;13(1):421.
[39] 房晓磊,冷军,张晨,等.间充质干细胞不同移植途径治疗缺血性脑卒中疗效差异的系统评价[J].中国组织工程研究,2022,26(7): 1085-1092.
[40] KATO Y, ABURAKAWA D, TASHIRO R, et al. Intravenous administration of muse cells improves cerebral ischemia outcome via immunomodulation in the spleen. J Cereb Blood Flow Metab. 2025;45(3):542-557. |